---------- Forwarded message ---------- From: kampower echez99@gmail.com Date: Tue, Jun 15, 2010 at 10:23 AM Subject: [canadareprap] Survey on Community expectations in RepRap and MakerBot governance To: Canadian RepRap Operators Group canadareprap@googlegroups.com
Hi everybody,
I'm a masters student at TUHH, Technical University of Hamburg. As part of my master’s thesis, I am carrying out a survey to better understand your experience and expectations with regards to the organization of Open design projects.
Your opinion as MakerBot and RepRap user and community member is very important to me! That's why I'm inviting you to fill out my survey. Answering the questions may take about 8-10 minutes. The individual responses will be kept strictly confidential, aggregated results will be published as soon as the survey is finished. If you are interested, I can also provide some specific results about the MakerBot and RepRap community.
Please follow this link or copy and or copy & paste it into your browser's address bar if that doesn't work.
http://cgi.tu-harburg.de/~somo1774/survey/index.php?sid=19333&newtest=Y&...
The survey is conducted on a per project basis. In case you receive my request more than once, it’s because you are involved in several communities. It would be great if you would fill out the survey more than once, for all projects which are relevant to you.
If you have any questions or concerns, please don't hesitate to contact me. If you are interested in more details about this research work, please take a look at: http://open-innovation-projects.org/my-research/#part3
Thank you very much for your help!
Best regards Marvelous
marvelous.onwukamike@tu-harburg.de
-- You received this message because you are subscribed to the Google Groups "Canadian RepRap Operators Group" group. To post to this group, send email to canadareprap@googlegroups.com. To unsubscribe from this group, send email to canadareprap+unsubscribe@googlegroups.com. For more options, visit this group at http://groups.google.com/group/canadareprap?hl=en.